Truist Securities Maintains Buy on Molina Healthcare, Lowers Price Target to $365
Portfolio Pulse from richadhand@benzinga.com
Truist Securities analyst David Macdonald maintains a Buy rating on Molina Healthcare (NYSE:MOH) but lowers the price target from $380 to $365.
June 20, 2023 | 1:26 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Truist Securities maintains a Buy rating on Molina Healthcare (NYSE:MOH) but lowers the price target from $380 to $365.
The news of Truist Securities maintaining a Buy rating on Molina Healthcare is positive for the stock. However, the lowering of the price target from $380 to $365 may create some uncertainty among investors. The overall impact on the stock price in the short term is expected to be neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100